Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001 China.
Cancer. 2010 Jun 1;116(11):2571-80. doi: 10.1002/cncr.24989.
BACKGROUND: Log odds of positive lymph nodes (LODDS) is defined as the log of the ratio between the probability of being a positive lymph nodes and the probability of being a negative lymph nodes when one lymph node is retrieved. The value of LODDS staging system on prognostic assessment for gastric cancer patients with R0 resection is still unclear. METHODS: Clinicopathologic and prognostic data of 2547 gastric cancer patients underwent D2 or D3 lymphadenectomy with R0 surgery were retrospectively studied. RESULTS: Multivariate analysis indentified LODDS stage was an independent prognostic factor, but not pN classification or rN classification. The scatter plots of the relationship between LODDS and the number, the ratio of nodes metastasis, suggested that the LODDS stage had power to divide patients with the same number or ratio of nodes metastasis into different groups. For patients in each of the pN or rN classifications, significant differences in survival could always be observed among patients in different LODDS stages. However, for patients in each LODDS stage, prognosis was highly homologous between those in different pN or rN classifications. A minimum number of 10, 15, 20, 25, and 10 nodes retrieved should be met for patients in the pN0, pN1, pN2, pN3, and rN0-3 classifications, respectively, unless the hazard risks of death would be underestimated or overestimated. However, LODDS stage could discriminate among 5 groups of patients with highly homologous prognosis, regardless how many nodes retrieved. CONCLUSIONS: The LODDS system is more reliable than the Union Internationale Contre le Cancer and American Joint Committee on cancer pN system and the rN system for prognostic assessment.
背景:淋巴结阳性对数 odds(LODDS)定义为在检测到一个淋巴结时,淋巴结阳性的概率与淋巴结阴性的概率之比的对数。对于 R0 切除的胃癌患者,LODDS 分期系统在预后评估中的价值尚不清楚。
方法:回顾性研究了 2547 例接受 D2 或 D3 淋巴结清扫术和 R0 手术的胃癌患者的临床病理和预后数据。
结果:多因素分析确定 LODDS 分期是独立的预后因素,但不是 pN 分期或 rN 分期。LODDS 与淋巴结转移数量、比例关系的散点图表明,LODDS 分期能够将具有相同数量或比例淋巴结转移的患者分为不同的组。对于每个 pN 或 rN 分类的患者,不同 LODDS 分期的患者的生存差异始终存在显著差异。然而,对于每个 LODDS 分期的患者,在不同 pN 或 rN 分类中的预后高度相似。对于 pN0、pN1、pN2、pN3 和 rN0-3 分类的患者,分别应至少检出 10、15、20、25 和 10 个淋巴结,除非死亡风险的危害被低估或高估。然而,无论检出淋巴结数量多少,LODDS 分期都可以区分预后高度相似的 5 组患者。
结论:与国际抗癌联盟和美国癌症联合委员会的 pN 系统和 rN 系统相比,LODDS 系统更可靠地用于预后评估。
Zhonghua Yi Xue Za Zhi. 2005-8-10
World J Gastrointest Oncol. 2025-3-15
Front Endocrinol (Lausanne). 2025-2-21
J Nanobiotechnology. 2024-12-19
World J Gastrointest Surg. 2023-11-27